Humana Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Humana Inc (HUM)
Humana Inc stock price live, this page displays NYSE HUM stock exchange data. View the HUM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Humana Inc real time stock price chart below.
What Is the Humana Inc Stock Price Today?
The Humana Inc stock price today is 363.86.
What Is the Stock Symbol for Humana Inc?
The stock symbol for Humana Inc is "HUM."
What Stock Exchange Does Humana Inc Trade On?
Humana Inc is listed and trades on the NYSE stock exchange.
Is Humana Inc a Good Stock to Buy?
Determining whether Humana Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HUM quote. (ISIN: US4448591028)
What Is the Humana Inc Stock Price Today?
The Humana Inc stock price today is 363.86.
What Is the Stock Symbol for Humana Inc?
The stock symbol for Humana Inc is "HUM."
What Stock Exchange Does Humana Inc Trade On?
Humana Inc is listed and trades on the NYSE stock exchange.
Is Humana Inc a Good Stock to Buy?
Determining whether Humana Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HUM quote. (ISIN: US4448591028)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
362.86
372.15
52 wk Range
163.11
428.88
HUM is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
362.86372.15
52 wk Range
163.11428.88
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.97%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.97%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HUM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
407.83
Upside
+12.08%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
14 analysts have revised their earnings downwards for the upcoming period
Humana Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
Humana Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Humana Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Humana Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Humana Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Humana Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
12 Buy
12 Hold
2 Sell
Ratings:
26 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 407.83
(+12.08% Upside)
Humana Inc SWOT Analysis
Medicare Maverick | Humana, a $30B market cap giant, dominates Medicare Advantage while facing regulatory hurdles and pursuing ambitious growth targets amidst fierce competition |
Financial Fortitude | Explore Humana's strong financial health, with more cash than debt and a "GOOD" overall score, despite recent stock volatility and analyst target ranges of $250-$353 |
Strategic Horizons | Delve into Humana's plan to achieve top-quartile Stars performance by 2028, potentially boosting EPS to $37-$44, with a focus on operational efficiency and CenterWell expansion |
Regulatory Roulette | Learn how ongoing Stars ratings litigation and conservative projections impact Humana's growth prospects, while the company navigates a complex healthcare regulatory landscape |
Humana Inc Earnings Call Summary for Q1/2026
- Humana Q1 2026 EPS of $10.31 beat forecast of $10.20; revenue hit $39.65B vs. expected $39.37B, though stock fell 2.58% in pre-market.
- Medicare Advantage margin expected to double in 2026, targeting sustainable 3% margin by 2028 through strategic pricing and operational efficiencies.
- Q2 2026 Medical Loss Ratio guidance set slightly above 91%; company maintains momentum from June 2025 Investor Day strategic expectations.
- Strategic acquisitions including MaxHealth to drive growth; CEO Rechtin affirmed Q1 results aligned with expectations despite funding gap challenges.
- Revenue grew 10.11% over twelve months to $129.7B; company faces headwinds from CMS rate-medical cost gap and regulatory uncertainty.
Last Updated: 2026-04-29, 09:10 a/m
Read Full TranscriptEarnings
Latest Release
Jul 29, 2026
EPS / Forecast
7.61 / 7.23
Revenue / Forecast
40.89B / 40.56B
Compare HUM to Peers and Sector
Metrics to compare | HUM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHUMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 34.2x | 15.6x | −0.3x | |
PEG Ratio | −1.82 | 0.38 | 0.00 | |
Price/Book | 2.3x | 2.0x | 2.6x | |
Price / LTM Sales | 0.3x | 1.6x | 3.0x | |
Upside (Analyst Target) | 14.1% | −5.7% | 56.3% | |
Fair Value Upside | Unlock | 0.0% | 9.2% | Unlock |
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Humana (HUM) Stock Price Today?
The Humana stock price today is 363.86 USD.
What Stock Exchange Does Humana Trade On?
Humana is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Humana?
The stock symbol for Humana is "HUM."
Does Humana Pay Dividends? What’s The Current Dividend Yield?
The Humana dividend yield is 0.97%.
What Is the Humana Market Cap?
As of today, Humana market cap is 43.69B USD.
What Is Humana's Earnings Per Share (TTM)?
The Humana EPS (TTM) is 10.59.
When Is the Next Humana Earnings Date?
Humana will release its next earnings report on Nov 06, 2026.
From a Technical Analysis Perspective, Is HUM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Humana Stock Split?
Humana has split 8 times.
How Many Employees Does Humana Have?
Humana has 67060 employees.
What is the current trading status of Humana (HUM)?
As of Aug 02, 2026, Humana (HUM) is trading at a price of 363.86 USD, with a previous close of 366.66 USD. The stock has fluctuated within a day range of 362.86 USD to 372.15 USD, while its 52-week range spans from 163.11 USD to 428.88 USD.
What Is Humana (HUM) Price Target According to Analysts?
The average 12-month price target for Humana is 407.83 USD, with a high estimate of 513 USD and a low estimate of 249 USD. 12 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +12.08% Upside potential.
What Is the HUM Premarket Price?
HUM's last pre-market stock price is 369.85 USD. The pre-market share volume is 540.00, and the stock has decreased by 3.19, or 0.87%.
What Is the HUM After Hours Price?
HUM's last after hours stock price is 363.60 USD, the stock has decreased by -0.26, or -0.07%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.